Concepedia
Statistics
Publications
13
Citations
1K
H-Index
12
Active since
1979
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
Northwestern University
Abbott Fund
Molecular Oncology (United States)
Linda J. Swanson is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacotherapy, and public health.
Top concepts
MedicinePharmacotherapyPhysiologyCell BiologyPharmacologyPublic HealthTumor BiologyOvarian CancerAnimal BehaviorReproductive Biology
Publications per year
1979–1998
Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics
Barbro Dahlén, Ewa Niżankowska, A Szczeklik et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 395 citations
BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway
Thomas Ströbel, Linda J. Swanson, Stanley J. Korsmeyer et al. · Proceedings of the National Academy of Sciences · 1996 · 223 citations · Full text
In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation.
Thomas Ströbel, Linda J. Swanson, S A Cannistra · PubMed · 1997 · 123 citations
Vivo Inhibition, Cd44 Function, Nude Mice +14
CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors.
S A Cannistra, Graziella M. Abu‐Jawdeh, Jonathan M. Niloff et al. · Journal of Clinical Oncology · 1995 · 94 citations
Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
Paul Rubin, Louise M. Dubé, Rene A. Braeckman et al. · PubMed · 1991 · 38 citations
Molecular Pharmacology, Oxysterol, Pharmacological Study +14
1–5 of 13